by
Brendon Nafziger, DOTmed News Associate Editor | January 28, 2010
"Many OEMs are interested in dose reduction, and my expectation is they would use this data for a human-based study," Barry says.
In the meantime, Barry is working on a project to compare image quality with the ContextVision enhancement software without the need to recruit people for a massive comparison study. In this experiment, a computer will randomly inject noise into existing radiographs, taken from humans, to mimic the effects of a low-dose image, which could then be corrected with the company's software. "If you know [that] the pattern you're putting in reflects a dose reduction of X percent, then you have a good surrogate of a low dose image," Barry says.
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Read more and watch a video on DOTmed:
Johns Hopkins University Study Proves Low-dose Capability of ContextVision Interventional Image Enhancement Tool
https://www.dotmed.com/news/story/11437
RSNA Video Profile: ContextVision
https://www.dotmed.com/news/story/10957
ContextVision's GOPView CT Achieves Unprecedented Image Enhancement Speed
https://www.dotmed.com/news/story/10514
ContextVision Software Is the "Brains" Behind Many Modalities
https://www.dotmed.com/news/story/9457
Back to HCB News
